
Opinion|Videos|January 7, 2026
Closing Thoughts from the Experts
This final segment consists of expert clinicians offering key takeaways to help pharmacists prepare for potential approvals and integrate new TNBC therapies into practice.
Advertisement
Episodes in this series

An expert pharmacist and physician offer their main takeaways from the recent clinical trial data in TNBC. Clinical pearls for pharmacists are offered that will help prepare them for potential approval of these pharmacotherapies.
Advertisement
Advertisement
Advertisement
Trending on Pharmacy Times
1
The Inflation Reduction Act and Oncology Drug Pricing: What Pharmacists Need to Know
2
FDA Fast Tracks First-in-Class TNFR2 Antibody as Chemotherapy-Free Strategy for Platinum-Resistant Ovarian Cancer
3
Yes, COVID-19 Is Still a Big Deal. Pharmacy Is the Tip of the Spear (and Needle)
4
Trump Executive Order Recommends Separating MMR Into 3 Shots
5


































































































